OBJECTIVES: This study aimed to evaluate risk factors that affect mitral valve (MV) repair outcomes.
INTRODUCTION
Mitral regurgitation (MR) is defined as systolic retrograde flow from the left ventricle into the left atrium. Despite substantial reduction in the incidence of rheumatic heart disease, MR is a growing public health problem with a 5-year mortality rate of 20-50% depending on the severity of regurgitation [1] . Mitral valve (MV) repair has become standard for MR, and recent reports have shown benefits including preserved ventricular function, improved quality of life, greater freedom from reoperation, lower operative mortality rates and improved medium-term survival [2, 3] .
However, for yet unexplained reasons, MV does not remain competent in some patients who undergo MV repair. In addition to the involvement of the leaflets, pulmonary hypertension, tricuspid regurgitation (TR), preoperative heart failure status and atrial fibrillation (AF) have been suggested to affect clinical outcomes and repair durability [4] [5] [6] [7] . Apart from MV repair expertise, patient selection and the correct indications for the concomitant procedure may significantly influence clinical results. Accordingly, we planned the present study to identify those variables that, in our experience, were associated with an increased risk of adverse medium-term outcomes of MV repair.
MATERIALS AND METHODS

Ethics approval
The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee and was approved by the Ethics Committee of the Capital Medical University. From each of the patients included in the present investigation, written consent was obtained to publish, in an anonymous format, clinical data collected during their clinical evaluation and treatment.
Study population
Between 2002 and 2012, 580 patients with MR underwent MV repair at our institution. Any MV repair done as a lone procedure or associated with any other cardiac procedures was included in this study. Data on pre-, intra-and postoperative variables were collected retrospectively from our database and patients' records by a single investigator. The mean patient age was 50 ± 14 years (range 18-79 years). Before surgery, 296 (51.0%) of the study patients were in New York Heart Association (NYHA) functional Class I or II; 284 (48.9%) were in Class III or IV. All patients had moderate to severe MR, and its aetiology was anterior leaflet (AL) prolapse in 202 (34.8%), posterior leaflet (PL) prolapse in 276 (47.6%) and bileaflet (BL) prolapse in 102 (17.6%). One hundred and seventy-two patients were in AF. The average AF duration was 3.2 ± 2.1 years. Demographic and operative data are summarized in Table 1 .
Echocardiography
The clinical echocardiographic evaluation was as follows. A transthoracic echocardiogram was performed before the operation and during follow-up. The left atrial diameter (LAD), left ventricular end-diastolic diameter and left ventricular end-systolic diameter (LVESD) were determined from parasternal M-mode acquisitions. The severity of valvular regurgitation was assessed semi-quantitatively on a scale of 0-4 (0 = none or trace, 1 = mild, 2 = moderate, 3 = moderate to severe, 4 = severe) [8] .
Surgical procedures
Operations were performed through median sternotomy, aortobicaval cannulation and the standard technique of cardiopulmonary bypass with moderate hypothermia. Myocardial protection was obtained with antegrade intermittent crystalloid or cold blood cardioplegia combined with topical cooling. The MV was exposed through standard left atriotomy.
The appropriate repair techniques were directed to specific structures of the MV (Table 2 ). Leaflet resection (e.g. quadrangular, triangular) was used in 237 (40.9%) patients, chordal reconstruction (replacement with artificial chordate or chordal transfer) was used in 194 (33.4%) and edge-to-edge repair was used in 173 (29.8%). Other techniques included commissuroplasty in 12 (19.3%) patients, leaflet augmentation in 9 (1.6%) and cleft closure in 23 (4.0%). Ring or band annuloplasty was performed in 572 (98.6%) patients. Annuloplasty devices such as flexible rings and bands were used. The chosen ring size was based on the surface area of the anterior mitral leaflet. Saline solution testing and intraoperative transoesophageal echocardiography after weaning from cardiopulmonary bypass were performed in all patients to ensure repair quality. Maze procedures were performed using a modified Cox maze III technique; the details of which have been described previously [9] . Concomitantly, a tricuspid valve annuloplasty was performed in 199 (34.3%) patients (severe or moderate TR with a dilated annulus ≥40 mm), aortic valve surgery was performed in 56 (9.7%), coronary artery bypass grafting was performed in 29 (5%), left atrial thrombectomy was performed in 2 (0.3%) and pericardiectomy was performed in 1 (0.2%).
Postoperative management
All patients were treated with warfarin during the first 3 months postoperatively with a target international normalized ratio of 2.0-2.5, which was continued at the discretion of the attending surgeon on the basis of freedom from AF and the CHADS 2 (C, Congestive heart failure; H, Hypertension; A, Age ≥75 years; D, Diabetes mellitus; S 2 , Prior Stroke or TIA or Thromboembolism) score. All antiarrhythmic drugs were discontinued starting from 3 months after the procedure.
Follow-up
During follow-up, patients were seen at the outpatient clinic at 6 and 12 months, and every 1 year thereafter. At each visit, patients were questioned for any adverse events and symptoms. A routine transthoracic echocardiogram and electrocardiography were taken at each visit for every patient until the latest follow-up. Any symptoms suggestive of arrhythmia were assessed by 24-h Holter monitoring during follow-up. Freedom from AF recurrence was defined as the absence of atrial arrhythmias without using any antiarrhythmic drugs after 3 months following the procedure, in accordance with the generally accepted consensus document of 2012 [10] . We used the published guidelines of the Society of Thoracic Surgeons/American Association for Thoracic Surgery [11] for reporting valve-related morbidity and mortality after valvular operation.
Complete follow-up information was available for 556 (95.9%) patients, while contact was lost with 24 during the follow-up period. The mean duration of follow-up for the survivors was 5.3 ± 2.6 (range 2.0-10.2) years. The time to event was measured from the MV repair in our study. The durability of MV repair was primarily assessed by the incidence of reoperation as well as by echocardiographic assessment. The durability of the maze procedure was assessed by electrocardiographic findings; other events briefly investigated included all-cause death, thromboembolism, bleeding and endocarditis.
Statistics
Continuous data are presented as means ± standard deviation and compared by using Student's t-test for paired data. Survival curves of the freedom from events were plotted via the Kaplan-Meier method and the statistical significance between curves was determined using the log-rank test. Logistic regression analysis was used to identify predictors of early mortality. A Cox proportional hazard regression analysis was performed for the determination of factors independently associated with long-term survival and freedom from events. Variables selected to be tested on multivariate analysis included those with P <0.1 on univariate analysis. All tests were two-tailed, and P <0.05 was considered significant. The data were analysed using SPSS for Windows version 17.0 (SPSS, Inc., Chicago, IL, USA).
RESULTS
Operative mortality and morbidity
Eight patients died in the hospital and were excluded from followup analysis. Two patients who could not be weaned from extracorporeal membrane oxygen (ECMO) died of persistent heart failure without any improvement in cardiac function. Additional causes of mortality included sepsis with consecutive multiorgan failure (3 patients), respiratory failure (2 patients) and cerebral infarction (1 patient). Five independent risk factors remained statistically significant on multivariate logistic regression analysis: New York Heart Association (NYHA) Class III/IV, left ventricular ejection fraction (LVEF) ≤50%, systolic pulmonary artery pressure (sPAP) ≥50 mmHg, AF and low cardiac output syndrome (LCOS) with ECMO (Table 3) .
Eight patients had sepsis, 7 had renal failure and required dialysis, 6 had respiratory failure, 5 had LCOS and required ECMO, 4 had stroke and 1 patient had perioperative myocardial infarction. Early reoperation was necessary for bleeding in 16 and sternal infection in 6 patients.
Predischarge surgical result of mitral valve repair
Predischarge transthoracic echocardiography was performed in all patients. Five hundred and thirty-seven patients (93.9%) had no or trace MR, whereas 35 (6.1%) had mild residual MR. Twenty-eight of those 35 patients had leaflet prolapse with AL involvement.
Late mortality and survival
There were 14 late deaths: cardiac-related in 10 patients, othercause related in 2 and of unknown cause in 2. The causes of cardiac-related deaths were congestive heart failure due to recurrent MR and ventricular dysfunction in 4 patients, sudden death due to malignant arrhythmias in 2, myocardial infarction in 1, stroke in 1 and after cardiac surgery for recurrent MR in 2. On multivariate Cox regression analysis, AF, NYHA Class III/IV, LVESD ≥40 mm and sPAP ≥50 mmHg remained significant factors for predicting late mortality (Table 3) .
The survival rate for all patients at 1 and 5 years was 100 and 99.0 ± 0.6%, respectively. Figure 1 shows Kaplan-Meier estimates of survival of the entire cohort and of patients with NYHA Class I/II versus III/IV, sPAP <50 vs ≥50 mmHg and LVESD <40 vs ≥40 mm.
Reoperations
Twenty-two patients required MV reoperation: 13 for moderate to severe MR caused by recurrent leaflet prolapse, 4 for haemolysis caused by residual MR, 3 for mitral stenosis caused by progressive rheumatic pathology and 2 for infective endocarditis. In addition, 1 patient had aortic valve replacement but did not require MV reoperation. A re-repair was performed in only the 3 earliest recurrent cases of MR (on postoperative days 1, 2 and 7) that occurred due to technical failure consisting of leaflet tear and annular suture leakage. The MV was replaced in the other 20 patients.
There was no significant difference in the freedom from reoperation between the different surgical repair strategies (Supplementary Figure) . Only AL involvement and predischarge residual MR more than Grade 2 were the independent predictors of MV reoperation by Cox regression analysis ( Table 3 ). The rate of freedom from reoperation at 5 years was 97.2 ± 0.8% ( Fig. 2A) , while freedom from reoperation according to the involved leaflet is shown in Fig. 2B . The rate of freedom from reoperation at 5 years was 99.5 ± 0.5% for patients with PL prolapse, 96.4 ± 1.7% for patients with AL prolapse and 90.6 ± 3.6% for patients with BL prolapse, respectively.
Recurrent mitral regurgitation
The latest echocardiogram showed that severe MR developed in 15 patients (11 underwent reoperation, 8 died) and moderate MR developed in 35 patients (2 underwent reoperation, 1 died of unknown causes and 32 survived). The rate of freedom from moderate to severe recurrent MR at 5 years was 93.3 ± 1.2% (Fig. 3A) .
There was no significant difference in the freedom from moderate to severe recurrent MR between the different surgical repair strategies (Supplementary Figure) . Only AL involvement and predischarge residual MR more than Grade 2 were the independent predictors of moderate-to-severe recurrent MR (Table 3 ). The rate of freedom from moderate-to-severe recurrent MR at 5 years was 95.5 ± 1.4% for patients with PL prolapse, 90.8 ± 2.5% for patients with AL prolapse and 87.3 ± 4.3% for patients with BL prolapse (Fig. 3B) .
Rhythm in patients after maze procedure
All patients with AF (n = 172) underwent a concomitant maze procedure. Three patients died in hospital. Sinus rhythm was regained in 168 (99.4%) patients after 6 months. The rate of freedom from recurrent AF at 1 and 5 years was 98.8 ± 0.8 and 92.7 ± 2.3%, respectively. There was no significant difference in the freedom from recurrence between the paroxysmal and long-standing persistent AF (Fig. 4) .
At the latest follow-up, 16 of 169 patients (9.5%) had recurrent AF, which persisted in 50.0% (9 of 18) of the patients with moderate-to-severe recurrent MR. Patients with recurrent AF also had a larger LAD and longer AF duration compared with those with sinus rhythm. Multivariate Cox regression analysis revealed that the LAD [hazard ratio (HR), 1.064; 95% confidence interval (CI) 1.027-1.149; P <0.001] AF duration (HR, 1.133; 95% CI 1.016-1.3859; P = 0.004) and moderate-to-severe recurrent MR (HR, 5.187; 95% CI 2.582-9.752; P <0.001) were the significant risk factors for AF recurrence. 
ORIGINAL ARTICLE
Progression of right ventricular dilatation and tricuspid regurgitation without tricuspid annuloplasty
In the entire cohort, only patients (n = 199) with severe or moderate TR and a dilated annulus ≥40 mm underwent tricuspid valve annuloplasty. At the 2-year follow-up, in these patients, TR was absent or mild and there was a significant decrease in the transtricuspid gradient during the follow-up period ( Fig. 5A and  B) . Moreover, these patients showed reverse right ventricular (RV) remodelling as expressed by significantly decreased RV long-and short-axis diameters ( Fig. 5C and D) . In the 267 patients without significant TR at baseline, the degree of TR remained unchanged. However, in patients (n = 114) who had moderate TR and an annulus <40 mm, the degree of TR at the 2-year follow-up was worse and the transtricuspid gradient increased significantly ( Fig. 5A and B) . Moreover, this was associated with RV dilatation (Fig. 5C and D) . Note that these patients did not undergo tricuspid annuloplasty.
DISCUSSION
Surgical treatment of MR is the only approach with defined clinical success that provides sustained relief of symptoms or heart failure. MV repair improves outcomes compared with valve replacement and reduces mortality rates of patients with severe organic MR by about 70% [12, 13] . The best short-and long-term results are obtained in asymptomatic patients who undergo surgery in advanced repair centres with low operative mortality (<1%) and high repair rates (≥80-90%) [14] . Our medium-term results were similar to those from centres with surgeons who were proficient in MV repair with a 5-year survival rate of 99.0 ± 0.6% and rate of freedom from reoperation of 97.2 ± 0.8%.
Major causes of surgical MR in our study were degenerative, representing 81.7% of cases, followed by post-rheumatic (8.3%), ischaemic (5.2%), endocarditis (3.4%) and of miscellaneous cause (traumatic and cardiomyopathy). We have not used a single technique to repair all valves in this series of patients; rather, we adapted our technique to the lesions seen in each valve, applying both resectional and non-resectional techniques. It is true that using a blend of techniques, rather than a single approach, is essential if the goal is to repair all MVs [2] .
The first finding of this study was the identification that, despite preservation of the mitral apparatus, LV dysfunction remains a major cause of poor short-term outcomes for patients with poor cardiac function represented by an LVESD >40 mm, low LVEF, NYHA functional class III and IV or postoperative LCOS, and lower late survival. This finding is consistent with many other groups' results that MV repair in patients with MR should be performed before NYHA Class III or IV symptoms develop [15, 16] .
Our study also confirms that preoperative sPAP is a powerful predictor of early and late survival after MR surgery. These results support a management strategy of surgical intervention for MR before sPAP reaches 50 mmHg [17] . Ghoreishi et al. even concluded that mild pulmonary hypertension (40 mmHg ≤ sPAP <50 mmHg) compromises outcomes after MV repair for MR. Referral for MV repair for MR should be considered in the presence of sPAP of 40 mmHg or greater. The evidence suggests that MV repair should be performed before the development of pulmonary hypertension.
The present study identified AL prolapse as an independent risk factor of freedom from reoperation. Numerous studies have documented that a high proportion of AL cases involved repair failure [5, 18] . They found a higher rate of reoperation in patients with AL-involved prolapse than that seen in patients with PL prolapse. The findings of the sequential echocardiographic studies in this series suggested that MV repair did not arrest the progression of the degenerative changes in the MV [5] . That was probably the reason why patients with AL and BL prolapse had higher reoperation rates during follow-up. Similarly, patients with AL-involved prolapse had a significantly higher recurrence rate of moderate to severe MR.
Predischarge residual MR more than Grade 2 was also found to be a significant risk factor for both reoperation and recurrent moderate to severe MR recurrence. The incidence of residual MR varies with the cause of the MR, the complexity of the repair, the experience of the surgeon and the threshold of the operative team to accept a suboptimal result. We rarely accept any degree of residual MR after PL repair on post-bypass transoesophageal echocardiography, while, if the residual MR is mild or less after AL and BL repair, then the result is usually accepted, which may cause progression of MR. Although predischarge residual MR more than Grade 2 did not increase morbidity or mortality, it did lead to a significantly higher rate of MR recurrence requiring reoperation, thus stressing the importance of achieving an initial leak-proof repair.
Preoperative AF is reported to be a marker of not only surgical risk but also of late adverse cardiac events and stroke; thus, sinus conversion is an important strategy for patients with AF, who are estimated to comprise 30-40% of all patients who require MV repair [19, 20] . In our study, AF was confirmed as an independent risk factor for early and late mortality. Therefore, a maze procedure is as important as MV repair for achieving a good mediumterm outcome. The success rate for the maze procedure was 99.4% in our series of patients at the 6-month follow-up, while the rate of freedom from recurrent AF at 1 and 5 years was 98.8 ± 0.8 and 92.7 ± 2.3%, respectively. Our results appear to show a superior therapeutic effect on AF compared with previous reports [9] . This could be due to the shorter duration of AF and smaller LAD, which may reflect the minor remodelling of the LA in the patients with MR. In addition to the transmural algorithm we used during bipolar ablation and the multiple isolation lesions, the epicardial electrophysiological testing we used allowed us to more precisely evaluate atrial lesion quality. Risk factors for AF recurrence in the present study were LAD and AF duration as shown in our earlier studies [9] . Moreover, multivariate analyses revealed that AF recurrence was also associated with moderate-to-severe recurrent MR, indicating that recurrent MR caused LA remodelling and may have contributed to AF recurrence. In combination with these, reverse remodelling is a key factor either for the durability of MV repair, or for AF ablation. Therefore, early indications of surgery before remodelling can contribute to the long-term durability of MV repair.
A novel finding of the current study was that in patients with moderate TR (even a tricuspid annulus) <40 mm undergoing MV repair without concomitant tricuspid surgery, RV dimensions increased and the TR was aggravated during the follow-up period. In contrast, RV reverse remodelling and absence of or mild TR was observed during the follow-up period in patients with severe or moderate TR and a dilated annulus ≥40 mm who underwent tricuspid annuloplasty during MV repair.
There is increasing evidence that TR does not always regress after successful surgical treatment of MR [21, 22] . Once the leftsided lesions have been addressed, a subsequent improvement in cardiac output may further increase RV preload and lead to higher end-diastolic RV volumes, particularly in patients with lesser degrees of preoperative TR. Indeed, increased preload and higher RV end-diastolic volumes may cause RV papillary muscle displacement and result in severe TR even in the absence of tricuspid annular dilatation. This subsequent increase in RV preload may be another important mechanistic cause of recurrent or progressive TR that is frequently observed late after MV surgery and constitutes the rationale for our surgeons to consider a more aggressive tricuspid annuloplasty in patients scheduled for left-sided heart surgery with at least moderate TR at the time of surgery despite the presence of annular dilatation.
The European Society of Cardiology and the European Association for Cardiothoracic Surgery (ESC/EACTS) 2012 guidelines recommend a more proactive approach to TR correction and highlight the shifting consensus towards more aggressive surgical therapy [17] . Importantly, they recommend that surgery should be considered in patients with mild or moderate secondary TR with a dilated annulus (≥40 mm or >21 mm/m 2 ) undergoing left-sided valve surgery (Class IIa). In our institution, concomitant tricuspid annuloplasty for TR at the time of MV surgery should be considered for patients with severe or moderate TR and an annulus ≥40 mm. Our results are in accordance with other recently published data demonstrating that tricuspid annuloplasty performed concomitantly with MV repair effectively inhibits ongoing RV dilatation and associated postoperative TR [23, 24] . These findings also suggest whether prophylactic tricuspid annuloplasty is necessary and reasonable for patients who have moderate MR and an annulus <40 mm to avoid recurrent or progressive TR during follow-up (i.e. lowers the threshold for concomitant tricuspid annuloplasty) [25] . Future well-powered randomized prospective studies are needed to bolster the current recommendation. Moreover, the relation between the post-bypass transoesophageal echocardiography and late results should also be elucidated in further study.
Obvious limitations inherent in the retrospective study design should be considered when these findings are interpreted. However, particular attention was paid to the methods used in the follow-up period by a thorough examination of the hospital database. The presence of associated disease (e.g. aortic valve, AF and coronary heart disease) may have also affected the outcomes. Moreover, upon covariate analysis of certain subgroups, the statistical power was low because of the small numbers of patients and events.
In addition, the decision regarding whether to use Kaplan-Meier methodology and censor patients at death, or use cumulative incidence, is a complex issue. The Kaplan-Meier method is usually used to estimate the occurrence of valve-related events. This method is not perfect because it assumes independence of death from the event of interest, which in most instances is not true. Inverse probability weighting may correct for this to provide a better estimate of true valve performance in future study.
CONCLUSIONS
The medium-term results were satisfactory; however, MV repair should be performed before the deterioration of ventricular function, development of pulmonary hypertension and AF occurrence. The pathophysiology of MR affected MV repair durability, and the PL prolapse results were better than those of AL and BL prolapse. Combined MV repair and tricuspid annuloplasty should be considered in patients with moderate TR despite tricuspid annular dilatation at baseline.
SUPPLEMENTARY MATERIAL
Supplementary material is available at ICVTS online. I have read with great interest the article by Wang et al. [1] . The conclusions emphazised by the authors are very interesting. However, several considerations must be pointed out. Carpentier's French correction has enabled the approach for mitral valve (MV) repair to be conducted in a standardized way. Posterior mitral leaflet prolapse (PMLP) is corrected by means of resection. Anterior mitral leaflet prolapse (AMLP) is solved by ePTFE neo-chordae. Both techniques are always completed with an annuloplasty ring. PMLP is relatively easy to correct. The problem is that many surgeons do not always have the required experience to repair the AMLP. As the authors state, "anterior leaflet involvement was predictive of reoperation and recurrent moderate-to-severe mitral regurgitation". In fact, increasing surgeon-specific annual MV volume is associated with a higher probability of MV repair [3] . In addition, the proposed standards for best practice in mitral valve repair include among others, a minimum level of 25 mitral repairs per surgeon per year, and 50 repairs per hospital per year to qualify as an experienced reference centre in MV repair [4] . In other words, the need for experienced centres is becoming more and more evident. The new 2014 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease indicate that MV repair is reasonable in asymptomatic patients with chronic severe primary MR with preserved LV function (LVEF >60% and LVESD <40 mm), in whom the likelihood of a successful and durable repair without residual MR is >95% with an expected mortality rate of <1% when performed at a Heart Valve Centre of Excellence [5] . In my opinion, it means that the "mitral valve surgeon" must be subject to approval by a body of his/her peers. At the same time, hospitals involved must be a centre of renowned expertise in this specific area. Otherwise, the outcome expected by the 2014 guideline proposal as regards the operation of asymptomatic patients with P2 prolapse (the only prolapse with a feasible repair success rate > 95% in the real world) in a prophylactic way will not be consistent.
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